Search filters
Termination TerugBetaalRegeling Fampyra®

Termination TerugBetaalRegeling Fampyra®

08/11/2019

Fampyra® is fully reimbursement from the 1st of September 2019. For this reason the co-payment for Fampyra ended per August 31,...

Launch of TerugBetaalRegeling Veltassa®

Launch of TerugBetaalRegeling Veltassa®

18/09/2019

The health insurer does not fully reimburse Veltassa® 8.4g. The producer of this medicine has therefore asked TBR Nederland to...

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

Amendment to TerugBetaalRegeling Forxiga® and Xigduo®

06/09/2019

The health insurer does not yet reimburse this medication as monotherapy or for specific combination treatment. The producer of...

Launch of TerugBetaalRegeling Lokelma®

Launch of TerugBetaalRegeling Lokelma®

01/09/2019

The health insurer does not fully reimburse Lokelma® 5g and 10g. The producer of this medicine has therefore asked TBR Nederland...

Relaunch of TerugBetaalRegeling Plenadren®

Relaunch of TerugBetaalRegeling Plenadren®

12/08/2019

The health insurer does not fully reimburse Plenadren® 5mg and 20mg. The producer of this medicine has therefore asked TBR...

Select your medicine

Check your medicine expenses

Quickly check the maximum contribution you have to pay for your medicine

Check Medicijnkosten

You are currently offline. Some pages or content may fail to load.